Promising Late-Stage Drugs Signal A New Treatment Era Delveinsight. The generalized myasthenia gravis treatment pipeline ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...
Alexion to deliver 20 presentations across gMG, NF1 plexiform neurofibromas and neuromyelitis optica spectrum disorder at AAN meeting: Cambridge, UK Saturday, April 11, 2026, 18:0 ...
RNA therapies present significant opportunities in targeting a broad range of diseases through various innovative approaches, including antisense oligonucleotides, siRNAs, mRNA vaccines, and aptamers.
EMPAVELI® (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced ...
Gov. Maura Healey proposed $227.3 million in additional spending Tuesday, mostly for snow and ice removal costs, in a bill ...
The fiscal year 2026 supplemental budget that Healey filed Tuesday afternoon seeks to make up the deficit left behind by a ...
A 2026 informational overview of the Gel Water Diet System program, gel water weight loss trend, hydration and metabolism ...
President John Mahama has cautioned Ghanaians against the habit of eating heavy meals late at night. He warned that such ...
Livestock farmers across South Africa could soon be allowed to vaccinate their own animals against foot-and-mouth disease ...
EMPAVELI (pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada Approval supported by Phase 3 52-week VALIANT study demonstrated reduced ...
GE HealthCare announces digital integration between bkActiv iUS system and Medtronic Stealth AXiS surgical navigation system: Chicago, Illinois ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results